These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 36685603)
1. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients. Filgueira TO; Carvalho PRC; de Sousa Fernandes MS; Castoldi A; Teixeira AM; de Albuquerque RB; de Lima-Filho JL; Souto FO Front Immunol; 2022; 13():1051059. PubMed ID: 36685603 [TBL] [Abstract][Full Text] [Related]
2. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone. Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC Front Immunol; 2023; 14():1229611. PubMed ID: 37662953 [TBL] [Abstract][Full Text] [Related]
3. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients. Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291 [TBL] [Abstract][Full Text] [Related]
4. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection. Majeed AY; Zulkafli NES; Ad'hiah AH Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685 [TBL] [Abstract][Full Text] [Related]
5. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients. Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255 [TBL] [Abstract][Full Text] [Related]
6. Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19. Körper S; Schrezenmeier EV; Rincon-Arevalo H; Grüner B; Zickler D; Weiss M; Wiesmann T; Zacharowski K; Kalbhenn J; Bentz M; Dollinger MM; Paul G; Lepper PM; Ernst L; Wulf H; Zinn S; Appl T; Jahrsdörfer B; Rojewski M; Lotfi R; Dörner T; Jungwirth B; Seifried E; Fürst D; Schrezenmeier H Front Immunol; 2022; 13():1008438. PubMed ID: 36275695 [TBL] [Abstract][Full Text] [Related]
7. IL-4, IL-10, CCL2 and TGF-β as potential biomarkers for severity in Plasmodium vivax malaria. Tovar Acero C; Ramírez-Montoya J; Velasco MC; Avilés-Vergara PA; Ricardo-Caldera D; Duran-Frigola M; Quintero G; Cantero ME; Rivera-Correa J; Rodriguez A; Fernanda Yasnot-Acosta M PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010798. PubMed ID: 36178979 [TBL] [Abstract][Full Text] [Related]
8. Patterns of cytokine and chemokine expression in peripheral blood of patients with COVID-19 associated with disease severity. Trifonova I; Ngoc K; Nikolova M; Emilova R; Todorova Y; Gladnishka T; Christova I Int J Immunopathol Pharmacol; 2023; 37():3946320231163681. PubMed ID: 36927211 [TBL] [Abstract][Full Text] [Related]
9. Enhanced Severe Acute Respiratory Syndrome Coronavirus 2 Antigen-Specific Systemic Immune Responses in Multisystem Inflammatory Syndrome in Children and Reversal After Recovery. Kumar NP; Venkataraman A; Nancy A; Moideen K; Varadarjan P; Selladurai E; Sangaralingam T; Selvam R; Thimmaiah A; Natarajan S; Ramasamy G; Hissar S; Radayam Ranganathan U; Babu S J Infect Dis; 2022 Sep; 226(7):1215-1223. PubMed ID: 35932220 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the inflammatory response to COVID-19 illness in pregnancy. Forrest AD; Poliektov NE; Easley KA; Michopoulos V; Ravi M; Cheedarla N; Neish AS; Cheedarla S; Roback JD; Dunlop AL; Badell ML; Dude CM Cytokine; 2023 Oct; 170():156319. PubMed ID: 37544133 [TBL] [Abstract][Full Text] [Related]
11. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113 [TBL] [Abstract][Full Text] [Related]
12. Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study. Fernandes GM; Sasaki LMP; Jardim-Santos GP; Schulte HL; Motta F; da Silva ÂP; de Carvalho AO; Pereira YR; Alves CO; de Araújo Júnior DA; Mendonça-Silva DL; Costa KN; de Castro MEC; Lauand L; Nery RR; Tristão R; Kurizky PS; Nóbrega OT; Espindola LS; de Castro LCG; Alpoim PN; Godoi LC; Dusse LMSA; Coelho-Dos-Reis JGA; do Amaral LR; Gomes MS; Bertarini PLL; Brito-de-Sousa JP; da Costa-Rocha IA; Campi-Azevedo AC; Peruhype-Magalhães V; Teixeira-Carvalho A; Zaconeta AM; Soares AASM; Valim V; Gomes CM; de Albuquerque CP; Martins-Filho OA; da Mota LMH Front Immunol; 2023; 14():1176898. PubMed ID: 37122732 [TBL] [Abstract][Full Text] [Related]
13. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355 [TBL] [Abstract][Full Text] [Related]
14. Corticosteroid inhibits chemokines production in systemic sclerosis patients. Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045 [TBL] [Abstract][Full Text] [Related]
15. Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome. Caldarale F; Giacomelli M; Garrafa E; Tamassia N; Morreale A; Poli P; Timpano S; Baresi G; Zunica F; Cattalini M; Moratto D; Chiarini M; Cannizzo ES; Marchetti G; Cassatella MA; Taddio A; Tommasini A; Badolato R Front Immunol; 2021; 12():654587. PubMed ID: 33841438 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293 [TBL] [Abstract][Full Text] [Related]
19. Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study. Gondim RNDG; de Arruda EAG; Neto RDJP; Medeiros MS; Quirino-Filho J; Clementino MA; Magalhães LMVC; Cavalcante KF; Viana VAF; Mello LP; Carlos LMB; Havt A; Lima AAM J Med Virol; 2023 Aug; 95(8):e29044. PubMed ID: 37605987 [TBL] [Abstract][Full Text] [Related]
20. Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes. Guo J; Lin WW; Zucker JE; Nandakumar R; Uhlemann AC; Wang S; Shivakoti R J Clin Endocrinol Metab; 2022 Apr; 107(5):e1961-e1968. PubMed ID: 34999821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]